Febuxostat is a xanthine oxidase inhibitor used for the long-term management of gout. It reduces uric acid levels in the blood, preventing urate crystal formation. Febuxostat is helpful for patients who cannot tolerate allopurinol. It is usually taken once daily after meals. The medicine lowers gout flare frequency over time. Common side effects include mild liver enzyme changes or nausea. Regular blood tests are recommended to monitor uric acid and liver function. It should not be started during an acute gout attack. Febuxostat provides effective control for chronic hyperuricemia. Doctor consultation is essential for dose adjustment.
